Allogene Therapeutics Inc (ALLO) Insider Trading
- $26,747,914.70
- $117,125,998.39
- May 30, 2024
- Veer Bhavnagri
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
May 30, 2024 | Director | 11,200 | $2.34 | Sell | $26,208.00 | |
May 16, 2024 | Director | 1,724,137 | $2.90 | Buy | $4,999,997.30 | |
Dec. 18, 2023 | Director | 18,640 | $2.70 | Sell | $50,328.00 | |
Aug. 7, 2023 | Director | 10,000 | $4.29 | Sell | $42,900.00 | |
Feb. 13, 2023 | General Counsel | 3,000 | $6.85 | Sell | $20,550.00 | |
Jan. 17, 2023 | General Counsel | 3,000 | $7.04 | Sell | $21,120.00 | |
Dec. 15, 2022 | General Counsel | 5,602 | $7.53 | Sell | $42,183.06 | |
Aug. 11, 2022 | Director | 10,000 | $16.50 | Sell | $165,000.00 | |
Aug. 2, 2022 | CMO | 2,000 | $11.97 | Sell | $23,940.00 | |
July 5, 2022 | CMO | 2,000 | $11.44 | Sell | $22,880.00 | |
June 22, 2022 | Director | 10,000 | $11.76 | Sell | $117,600.00 | |
June 21, 2022 | CMO | 2,000 | $11.18 | Sell | $22,360.00 | |
May 19, 2022 | CMO | 11,500 | $7.40 | Sell | $85,100.00 | |
March 15, 2022 | General Counsel | 8,849 | $7.68 | Sell | $67,960.32 | |
March 15, 2022 | CMO | 5,169 | $7.71 | Sell | $39,852.99 | |
March 15, 2022 | CFO | 11,469 | $7.63 | Sell | $87,508.47 | |
March 15, 2022 | CEO | 23,648 | $7.65 | Sell | $180,907.20 | |
March 15, 2022 | Insider | 8,698 | $7.63 | Sell | $66,365.74 | |
Jan. 12, 2022 | Director | 155,039 | $12.60 | Buy | $1,953,491.40 | |
Oct. 1, 2021 | CMO | 11,507 | $24.35 | Sell | $280,195.45 | |
Sept. 9, 2021 | Director | 5,000 | $25.54 | Sell | $127,700.00 | |
Aug. 20, 2021 | Director | 10,000 | $23.47 | Sell | $234,700.00 | |
Aug. 16, 2021 | General Counsel | 5,000 | $21.00 | Sell | $105,000.00 | |
July 15, 2021 | General Counsel | 5,000 | $21.55 | Sell | $107,750.00 | |
June 9, 2021 | Director | 9,969 | $25.05 | Sell | $249,723.45 | |
May 18, 2021 | General Counsel | 5,000 | $30.00 | Sell | $150,000.00 | |
April 15, 2021 | General Counsel | 10,000 | $32.05 | Sell | $320,500.00 | |
Jan. 14, 2021 | CFO | 15,000 | $30.77 | Sell | $461,550.00 | |
Oct. 15, 2020 | CFO | 15,000 | $40.49 | Sell | $607,350.00 | |
Oct. 13, 2020 | Insider | 35,264 | $42.00 | Sell | $1,481,088.00 | |
Oct. 9, 2020 | Insider | 44,574 | $41.00 | Sell | $1,827,534.00 | |
Oct. 7, 2020 | CMO | 16,538 | $39.40 | Sell | $651,597.20 | |
Oct. 6, 2020 | Insider | 44,574 | $40.00 | Sell | $1,782,960.00 | |
Oct. 6, 2020 | General Counsel | 10,000 | $40.00 | Sell | $400,000.00 | |
Oct. 1, 2020 | General Counsel | 25,000 | $36.52 | Sell | $913,000.00 | |
Sept. 21, 2020 | CFO | 15,000 | $35.30 | Sell | $529,500.00 | |
Aug. 3, 2020 | General Counsel | 31,553 | $36.89 | Sell | $1,163,990.17 | |
June 29, 2020 | Major Shareholder | 24,904 | $43.27 | Sell | $1,077,596.08 | |
June 26, 2020 | Major Shareholder | 500 | $44.01 | Sell | $22,005.00 | |
June 24, 2020 | Major Shareholder | 15,269 | $43.93 | Sell | $670,767.17 | |
June 22, 2020 | Major Shareholder | 172,425 | $42.83 | Sell | $7,384,962.75 | |
June 19, 2020 | Major Shareholder | 47,767 | $42.04 | Sell | $2,008,124.68 | |
June 17, 2020 | Major Shareholder | 87,319 | $42.18 | Sell | $3,683,115.42 | |
June 15, 2020 | Major Shareholder | 129,154 | $42.14 | Sell | $5,442,549.56 | |
June 4, 2020 | Director | 146,382 | $43.00 | Buy | $6,294,426.00 | |
June 3, 2020 | Major Shareholder | 487,402 | $47.40 | Sell | $23,102,854.80 | |
March 16, 2020 | Insider | 3,750 | $19.19 | Sell | $71,962.50 | |
March 16, 2020 | CFO | 5,450 | $19.73 | Sell | $107,528.50 | |
March 16, 2020 | CEO | 20,335 | $19.31 | Sell | $392,668.85 | |
Sept. 18, 2019 | Insider | 48,827 | $32.11 | Sell | $1,567,834.97 |
Insiders are both buying and selling Allogene Therapeutics Inc stock.
The insider traders at Allogene Therapeutics Inc are: Veer Bhavnagri, Group Holdings (Sbs) Advis Tpg, Alison Moore, Rafael Amado, Eric Thomas Schmidt, Arie Belldegrun, Owen N Witte, David D Chang, Owen N. Witte, Deborah M Messemer, Stephen Mayo, and Franz B Humer
The most active insider trader at Allogene Therapeutics Inc is Veer Bhavnagri with 11 trades.
Group Holdings (Sbs) Advis Tpg has sold the most Allogene Therapeutics Inc stock with a total value of $100,842,593.44.
Group Holdings (Sbs) Advis Tpg has bought the most Allogene Therapeutics Inc stock with a total value of $24,300,000.00.
The most recent insider trade for Allogene Therapeutics Inc was on May 30, 2024.
The single biggest insider buy for Allogene Therapeutics Inc was from Group Holdings (Sbs) Advis Tpg with a total value of $12,150,000.00 on Oct. 15, 2018.
The single biggest insider sell for Allogene Therapeutics Inc was from Group Holdings (Sbs) Advis Tpg with a total value of $56,373,021.90 on May 14, 2019.